Repare Therapeutics Inc. – Filings and Transcripts – BamSEC

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

SEC EDGAR

Financials Filter

ended 09/30/25 Q3

ended 06/30/25 Q2

ended 03/31/25 Q1

ended 12/31/24 FY 2024

ended 09/30/24 Q3

Prospectuses and Registrations Filter

Securities registration termination

Removal from listing

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Amendment to registration of securities for employees

Ownership Filter

Biotechnology Value Fund L P, Bvf Partners L P/Il, Bvf Inc/Il, Biotechnology Value Fund II LP, Lampert Mark N, Biotechnology Value Trading Fund OS LP, BVF Partners OS Ltd., Bvf I GP LLC, Bvf II GP LLC, Bvf GP Holdings LLC

Biotechnology Value Fund L P

Alves Sandra Isabelle Barros

News Filter

Announces Completion of Acquisition by XenoTherapeutics, Inc

Shareholders Approve Acquisition by XenoTherapeutics, Inc

Announces Acquisition of Polθ ATPase Inhibitor, RP-3467, by Gilead Sciences for Up to $30 Million in Total Consideration

Change in Directors, Officers or Compensation

Material Definitive Agreement, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Additional info about upcoming vote

Proxy related to merger

Additional info about upcoming vote

Preliminary proxy related to merger

Other Filter

Notice of effectiveness

Scanned paper annual report submission

Notice of effectiveness

Correspondence with the SEC

Letter from the SEC